Company Filing History:
Years Active: 2011
Title: Seppo Yla-Herttuala: Innovator in Angiogenic Research
Introduction
Seppo Yla-Herttuala is a prominent inventor based in Helsinki, Finland. He is known for his significant contributions to the field of angiogenesis, particularly through his innovative research and patents. His work has implications for various medical applications, especially in the treatment of cardiovascular diseases.
Latest Patents
Yla-Herttuala holds a patent for a modified form of VEGF-A, which has improved angiogenic properties. The patent describes methods and compositions for creating chimeric polypeptides that include a VEGFR-2 ligand. These chimeric molecules maintain VEGFR-2 binding activity while exhibiting enhanced angiogenic activity compared to native VEGF-A. This advancement could lead to more effective therapies in promoting blood vessel formation.
Career Highlights
Throughout his career, Seppo Yla-Herttuala has made significant strides in the field of biomedical research. His work has been instrumental in understanding the mechanisms of angiogenesis and developing therapeutic strategies to harness these processes for medical benefit. He is associated with Vegenics Pty Limited, where he continues to advance his research.
Collaborations
Yla-Herttuala has collaborated with notable researchers in his field, including Kari Alitalo and Tuomas Tammela. These partnerships have fostered innovation and contributed to the advancement of knowledge in angiogenic therapies.
Conclusion
Seppo Yla-Herttuala's contributions to the field of angiogenesis through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for new therapeutic approaches in medicine.